Shoko Matsui
University of Toyama
PathologyLung cancerIgG4-related diseaseDiabetes mellitusMedicine
What is this?
Publications 98
#1Takuji Nakamura (Kanazawa Medical University)H-Index: 8
#2Tomomi Satoh-Nakamura (Kanazawa Medical University)H-Index: 2
Last. Hisanori Umehara (Kanazawa Medical University)H-Index: 19
view all 28 authors...
AbstractBackground: IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. The pathogenesis of this disease is not clear. Tran...
#1Yuhei Fujisawa (Kanazawa University)H-Index: 2
#2Ichiro Mizushima (Kanazawa University)H-Index: 12
Last. Mitsuhiro Kawano (Kanazawa University)H-Index: 30
view all 14 authors...
AbstractObjectives: This study investigated the clinical features of IgG4-RKD patients with hypocomplementemia compared with those without it, so as to clarify the factors related to hypocomplement...
#1Takafumi Niwamoto (Kyoto University)H-Index: 1
#2Tomohiro Handa (Kyoto University)H-Index: 24
Last. Toyohiro Hirai (Kyoto University)H-Index: 30
view all 12 authors...
AbstractObjectives: Immunoglobulin G4-related disease (IgG4-RD) is a systemic, multiorgan disease of unknown etiology. We aimed to classify IgG4-RD by a combination pattern of affected organs and i...
2 CitationsSource
#1Minehiko Inomata (University of Toyama)H-Index: 7
#2Tomonobu Kado (University of Toyama)H-Index: 4
Last. Kazuyuki TobeH-Index: 66
view all 14 authors...
BACKGROUND/AIM: Little information is available about the association between peripheral T-lymphocyte expression of programmed cell death protein 1 (PD1) and the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer (NSCLC). We analyzed the PD1 and cytotoxic T-lymphocyte associated protein 4 (CTLA4) expression in peripheral blood T-lymphocytes of patients with NSCLC receiving immune checkpoint inhibitor therapy. PATIENTS AND METHODS: Patients with NSCLC who ...
#1Chikashi Terao (Kyoto University)H-Index: 25
#2Masao Ota (Shinshu University)H-Index: 1
Last. Chiharu KawanamiH-Index: 1
view all 69 authors...
Summary Background IgG4-related disease is a newly recognised immunopathological entity that includes autoimmune pancreatitis, IgG4-related sialadenitis, and IgG4-related kidney disease. To understand the genetic landscape of IgG4-related disease, we did a genome-wide association study. Methods We did a genome-wide association study of Japanese individuals, initially screening 857 patients with IgG4-related disease at 50 Japanese research institutions and DNA samples from 2082 healthy control pa...
8 CitationsSource
#1Hiroshi Yamamoto (Shinshu University)H-Index: 57
#2Masanori Yasuo (Shinshu University)H-Index: 20
Last. Masayuki Hanaoka (Shinshu University)H-Index: 27
view all 11 authors...
Abstract Background We previously reported that the cytokine profiles in the bronchoalveolar lavage fluid (BALF) of IgG4-related respiratory disease (IgG4-RRD) more closely resemble the T-helper (Th) 2 response than sarcoidosis. The present study aimed to assess the chemokines in the BALF of IgG4-RRD and sarcoidosis in order to evaluate any possible associations between these chemokines and other markers. Methods We examined 12 chemokines using a MILLIPLEX® MAP Kit (Millipore, Darmstadt, Germany...
#1Hajime YoshifujiH-Index: 21
#2Mirei ShirakashiH-Index: 2
Last. Mimori TsuneyoH-Index: 56
view all 25 authors...
#1Shoko Matsui (University of Toyama)H-Index: 21
#2Seisuke Okazawa (University of Toyama)H-Index: 7
Last. Kazuyuki Tobe (University of Toyama)H-Index: 66
view all 11 authors...
#1Shoko Matsui (University of Toyama)H-Index: 21
AbstractIgG4-related diseases (IgG4-RDs), such as autoimmune pancreatitis and IgG4-related Mikulicz disease, are often accompanied by intrathoracic lesions, which are called IgG4-related respirator...
1 CitationsSource
#1Mirei Shirakashi (Kyoto University)H-Index: 2
#2Hajime Yoshifuji (Kyoto University)H-Index: 21
Last. Mimori Tsuneyo (Kyoto University)H-Index: 56
view all 25 authors...
Glucocorticoids (GC) are effective for treating IgG4-related disease (IgG4-RD); however, relapse is often observed. We conducted a retrospective multicentre study to investigate risk factors in GC regimens associated with relapses of IgG4-RD. Data on 166 patients with definitive IgG4-RD diagnosis were collected from 12 institutions. Comprehensive surveillance of clinical backgrounds and GC regimens as well as multivariate analysis of factors associated with treatment responses and relapses was p...
5 CitationsSource